Manansad, Stephen Jay C.
HRN: 11-96-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2022
CEFUROXIME 1.5GM (VIAL)
11/19/2022
11/26/2022
IV
400mg
Q8
Febrile Neutropenia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Febrile Neutropenia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes